BRNS

Barinthus Biotherapeutics

15 hedge funds and large institutions have $22.2M invested in Barinthus Biotherapeutics in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$217K
2 +$41.5K
3 +$39.8K
4
Millennium Management
Millennium Management
New York
+$23.9K

Top Sellers

1 -$4.93K
2 -$3.38K
3 -$1.77K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$10.4M
2
$3.56M
3
$3.34M
4
$1.51M
5
$1.43M
6
$1.28M
7
$254K
8
$217K
9
$97K
10
$50.2K
11
$41.5K
12
$39.8K
13
$27.8K
14
$8.81K
15
$282